“In Silico Design and Validation of CRISPR-Cas13a System as a Potential Antiviral for SARS-CoV-2 in Indonesia” (2022) Nusantara Science and Technology Proceedings, pp. 44–51. doi:10.11594/nstp.2022.2107.